Committed to sharing our science

Committed to sharing our science

376 results available

Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

Oral Presentation, HFSA 2024

Maron, MS et al

September 30, 2024
Beta-blocker Use and Incidence of New Atrial Fibrillation or Flutter Requiring Therapy in Post-septal Myectomy Hypertrophic Cardiomyopathy Patients

Poster, HCM Society 2024

Kim M, et al

September 27, 2024
Global Remodeling Changes with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy: An Analysis of the SEQUOIA-HCM Trial

Oral Presentation, HCM Society 2024

Owens, AT et al

September 27, 2024
Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants

Poster, American College of Clinical Pharmacology 2024

Maharao N, et al

September 8, 2024
A First-in-Human, Single and Multiple Ascending Dose Study of CK-4021586, a Novel Cardiac Myosin Inhibitor

Poster, American College of Clinical Pharmacology 2024

Lutz JD, et al

September 8, 2024